Velum Ventures

Velum Ventures is a Medellin-based fund focused on early-stage Colombian and broader Andean technology companies, with explicit positioning around scalable B2B models. Check sizes of $250k to $1M place the firm in the seed range, capable of leading small priced rounds or anchoring the institutional portion of an angel-heavy raise. Healthcare exposure is read through digital health and health IT, which fits the firm’s general B2B software pattern.

The firm’s natural fit is with Colombian or Andean founders building B2B software with defined enterprise customers, including healthcare-specific software for clinics, hospitals, payers, pharmacies, or diagnostic chains. The firm is not specifically AI-focused, so AI-first founders should anchor the pitch in commercial outcomes (revenue, retention, gross margin) rather than model architecture. Founders building deep clinical assets, biotech, or consumer DTC are not the natural pattern. Founders without a Colombian or Andean operational footprint will find the strategic value thinner.

Geographically, the advantage is Velum’s local network in Medellin, which has emerged as a credible Latin American startup hub with strong technical talent at lower cost than Mexico City or Sao Paulo. For founders looking to build a Latin American B2B SaaS company with Medellin or Bogota as an operational base, Velum is a useful early partner. The firm can plausibly help with Colombian regulatory navigation, talent recruiting, and connection to regional follow-on capital.

The right entry path is a warm intro from a portfolio founder or another regional VC. Velum reads partner-led decks and is responsive to clear Andean expansion theses. The pitch should lead with the Colombian wedge, the path to regional expansion (Mexico, Chile, Peru as the typical next markets), and a credible plan for follow-on capital from larger LatAm or US funds. Healthcare-specific pitches should include a clear answer to the question of how the product navigates fragmented Colombian payer and provider dynamics.

Caveats. Colombian fund structures interact with cross-border venture dynamics in ways that require deliberate corporate structuring; talk to a regional corporate counsel before signing. The firm’s healthcare-specific portfolio depth is not as visible publicly as its broader B2B SaaS portfolio; do reference calls with two existing portfolio founders before assuming healthcare specialization. The $250k to $1M range is narrow; for founders raising larger seeds, Velum should be a participant alongside a real lead. For Colombian or Andean B2B health-tech founders, Velum is a credible early partner; for founders without regional ties, the strategic value is limited.